Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 154

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1
Chunk 154
---
 resources. Any of
the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.

Intellectual property rights do not necessarily address all potential
threats to our competitive advantage.

Once granted, patents may remain open to invalidity challenges including
opposition, interference, re-examination, post-grant review, inter partes review, nullification or derivation
action in court or before patent offices or similar proceedings for a given period after allowance or grant, during which time third parties
can raise objections against such grant. In the course of such proceedings, which may continue for a protracted period of time, the patent
owner may be compelled to limit the scope of the allowed or granted claims thus attacked, or may lose the allowed or granted claims altogether.

In addition, the degree of future protection afforded by our intellectual
property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business, provide
a barrier to entry against our competitors or potential competitors, or permit us to maintain our competitive advantage.

Moreover, if a third party has intellectual property rights that cover
the practice of our technology, we may not be able to fully exercise or extract value from our intellectual property rights. The following
examples are illustrative:

●others may be able to make formulations or compositions that
are the same as or similar to product candidates, but that are not covered by the claims of the patents that we own;

●others may be able to make product candidates that are similar
to product candidates that we intend to commercialize that are not covered by the patents that we exclusively licensed and have the right
to enforce;

●we, our licensor or any collaborators might not have been
the first to make or reduce to practice the inventions covered by the issued patents or pending patent applications that we own or have
exclusively licensed;

●we or our licensor or any collaborators might not have been
the first to file patent applications covering certain of our inventions;

●others may independently develop similar or alternative technologies
or duplicate any of our technologies without infringing our intellectual property rights;

●issued patents that we own or have exclusively licensed may
not provide us with any competitive advantages, or may be held invalid or unenforceable as a result of legal challenges;

78

●our competitors might conduct research and development activities
in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development
activities, as well as in